These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 27113935

  • 21. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L, Chu F, Cao Y, Shao J, Wang F.
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
    Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW.
    Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
    Wang K, Guo WX, Li N, Gao CF, Shi J, Tang YF, Shen F, Wu MC, Liu SR, Cheng SQ.
    PLoS One; 2015 Aug; 10(12):e0144934. PubMed ID: 26674525
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 30. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
    Okajima W, Komatsu S, Ichikawa D, Miyamae M, Kawaguchi T, Hirajima S, Ohashi T, Imamura T, Kiuchi J, Arita T, Konishi H, Shiozaki A, Moriumura R, Ikoma H, Okamoto K, Taniguchi H, Itoh Y, Otsuji E.
    Oncotarget; 2016 Aug 16; 7(33):53820-53836. PubMed ID: 27462777
    [Abstract] [Full Text] [Related]

  • 31. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK, Shaker OG, El-Maraghy SA, Senousy MA.
    PLoS One; 2015 Aug 16; 10(9):e0137706. PubMed ID: 26352740
    [Abstract] [Full Text] [Related]

  • 32. Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC.
    Luo P, Liang C, Zhang X, Liu X, Wang Y, Wu M, Feng X, Tu J.
    Biosci Rep; 2018 Aug 31; 38(4):. PubMed ID: 29559565
    [Abstract] [Full Text] [Related]

  • 33. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma.
    Li Z, Zhou Y, Yang G, He S, Qiu X, Zhang L, Deng Q, Zheng F.
    Clin Chim Acta; 2019 May 31; 492():37-44. PubMed ID: 30716279
    [Abstract] [Full Text] [Related]

  • 34. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
    Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996
    [Abstract] [Full Text] [Related]

  • 35. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM, Teng F.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(4):4008-14. PubMed ID: 26097588
    [Abstract] [Full Text] [Related]

  • 36. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F, Ying H, He B, Pan Y, Sun H, Wang S.
    Tumour Biol; 2016 Apr 01; 37(4):4945-53. PubMed ID: 26531720
    [Abstract] [Full Text] [Related]

  • 37. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT, Lo CM, Wong N, Li CX, Qi X, Liu XB, Geng W, Yeung OW, Ma YY, Chan SC, Man K.
    Oncotarget; 2016 Apr 12; 7(15):19824-39. PubMed ID: 26918346
    [Abstract] [Full Text] [Related]

  • 38. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance.
    Luo P, Jing W, Zhu M, Li ND, Zhou H, Yu MX, Liang CZ, Tu JC.
    Cancer Biomark; 2017 Apr 12; 18(3):285-290. PubMed ID: 28085012
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.